CLINICAL_TRIALS
trial_result
· 2019-09-26
Clinical Trial Update: WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8 [Phase 2, Phase 3]
Summary
A clinical trial comparing SR8 and CR8 for Mycobacterium ulcerans infection has completed Phase 2 and Phase 3.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Medical Center Groningen | Conditions: Mycobacterium Ulcerans Infection | Phase 2, Phase 3 | Status: COMPLETED